Latest AI and machine learning research in allergy for healthcare professionals.
Airborne fungi are potent inducers of respiratory disease and cause the debilitating conditions seve...
Fragile X Syndrome (FXS) is a rare neurodevelopmental disorder caused by a trinucleotide repeat expa...
The exact mechanisms underlying paediatric abdominal pain (AP) remain unclear due to patient heterog...
Post-translational modifications (PTMs) represent a fourth dimension of the genetic code, orchestrat...
Tertiary lymphoid structures (TLSs) within the tumor microenvironment have emerged as potential indi...
Structural neuroimaging analyses require ‘research quality’ images, acquired with costly MRI acquisi...
Despite biomarker-guided treatment strategies, clinical outcomes among patients with type 2 (T2)-hig...
Microsatellite instability (MSI) is a key biomarker for immunotherapy response and prognosis across ...
Immunotherapy has improved outcomes for advanced-stage melanoma, however, predictive biomarkers rema...
Cancer therapeutic response patterns may be fundamentally influenced by embryonic germ layer origin....
Immune checkpoint inhibitors have become standard care across many cancers, but most patients do not...
The rapid integration of Large Language Models (LLMs) into healthcare raises critical questions rega...
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer. However, ...
Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome/toxic epidermal necro...
Large language models (LLMs) have shown incredible promise in medicine. While LLMs may be particular...
Immunotherapy has improved outcomes in non-small cell lung cancer (NSCLC), but only a subset of pati...
Keratoconus (KC) is a prevalent ectatic corneal disease and the leading cause of corneal transplanta...
BACKGROUND: Lung adenocarcinoma (LUAD) is a major cause of cancer mortality. Considering the critica...
BACKGROUND: Although immune checkpoint inhibitors (ICIs) represent a substantial breakthrough in can...
Survival is the gold standard in oncology when determining the real impact of therapies in patients ...
BACKGROUND: Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited therape...